KFDA to rate pharmaceutical company by drug adverse reports.

Published: 2006-05-02 07:00:00

Updated: 2006-05-02 07:00:00

In an attempt to activate the drug adverse report activities at all concerned authorities, the KFDA announced on April 25 that the relevant health agencies should collect drug adverse reaction reports on quarterly basis, the drug adverse reaction reports adopted as an assessment criterion for the...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK